TSO3 Inc. has appointed Steve West to the Company's board of directors. West brings a wealth of strategic experience to TSO3, including more than 30 years of public company experience in health and life sciences, nuclear industry, specialty chemicals and venture capital. West recently served as CEO of Nordion.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | +0.59% | +12.50% |
2019 | 9402-4874 Québec Inc. completed the acquisition of TSO3 Inc.. | CI |
2019 | Tso3 Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 | CI |
- Stock Market
- Equities
- TOS Stock
- News TSO3 Inc.
- TSO3 Appoints Steve West to Board of Directors